文献速递头颈外科

美国软腭鳞状细胞癌:基于人群的研究

Squamous Cell Carcinoma of the Soft Palate in the United States: A Population-Based Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-05-08

该研究利用SEER数据库1973至2015年数据,回顾性分析4366例软腭鳞状细胞癌患者的人口学特征与生存情况。多因素分析显示性别、分期和治疗是疾病特异性生存的独立影响因素,年龄、分期和治疗则是总生存的独立影响因素。I至III期单纯放疗与单纯手术的总生存获益几乎相当,IV期手术联合放疗的总生存获益最大。

要点

  • I至III期软腭鳞癌单纯放疗与单纯手术的总生存获益几乎相当。
  • IV期患者接受手术联合放疗的中位总生存达50.0个月,显著更高。
  • 总生存与疾病特异性生存差异大,可能源于显著合并症。

核心结论

  • I至III期软腭鳞癌单纯放疗与单纯手术的总生存获益几乎相当,IV期手术联合放疗提供最大生存获益。
  • 总生存与疾病特异性生存间的大差异可能归因于显著合并症。

研究设计与样本

  • 回顾性、基于人群的队列研究,使用SEER癌症登记数据库1973至2015年数据。
  • 共纳入4366例软腭鳞状细胞癌患者,分析人口学特征与生存情况。

主要发现

  • 平均总生存为68.7个月,平均疾病特异性生存为161.3个月。
  • 多因素分析显示男性、分期和治疗是疾病特异性生存的独立影响因素(HR=0.690,P=.019;HR=1.73,P<.001;HR=0.64,P<.001)。
  • 年龄、分期和治疗是总生存的独立影响因素(HR=1.02,P<.001;HR=1.49,P<.001;HR=0.66,P<.001;HR=0.48,P<.001)。
  • I至III期单纯放疗与单纯手术的总生存几乎相当;IV期手术联合放疗的中位总生存显著更高,为50.0个月。

临床怎么用

  • I至III期软腭鳞癌可考虑单纯放疗或单纯手术,两者总生存获益几乎相当。
  • IV期软腭鳞癌推荐手术联合放疗以获得最大生存获益。
  • 治疗决策时需关注合并症对总生存的潜在影响。

局限性

  • 总生存与疾病特异性生存间的大差异可能源于显著合并症,但研究未具体分析合并症。
  • 未来研究应关注影响生活质量变量及治疗决策的因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives To describe the incidence and determinants of survival of patients with squamous cell carcinoma of the soft palate (SCCSP) using the Surveillance, Epidemiology, and End Results (SEER) database. Study Design Retrospective, population-based cohort study of patients. Setting SEER cancer registry. Subjects and Methods Patients from the SEER cancer registry from 1973 to 2015 were used to analyze demographics and survival of SCCSP. Results A total of 4366 cases were identified. The average overall survival (OS) and disease-specific survival (DSS) were 68.7 months and 161.3 months, respectively. Multivariate analysis revealed that male sex, stage, and treatment (hazard ratio [HR] = 0.690, P = .019; HR = 1.73, P < .001; HR = 0.64, P < .001, respectively) were independent determinants of better or worse DSS. Age, stage, and treatment (HR = 1.02, P < .001; HR = 1.49, P < .001; HR = 0.66, P < .001; HR = 0.48, P < .001, respectively) were independent determinants of better or worse OS. For stages I, II, and III, radiation alone and surgery alone have nearly equivalent OS. Patients with stage IV disease who underwent both surgery and radiation had a significantly higher median OS at 50.0 months. Conclusion Radiation alone and surgery alone both have nearly equivalent OS benefit for stages I to III, while surgery and radiation provide the most survival benefit for stage IV disease. The large discrepancy between OS and DSS can be due to significant comorbidities. Future studies should aim to address the determinants of quality-of-life variables that help direct treatment decisions and might indirectly affect survival.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Chan CK, Han AY, Alonso JE, et al. Squamous Cell Carcinoma of the Soft Palate in the United States: A Population-Based Study. Otolaryngol Head Neck Surg. 2018. PMID: 29734872. doi:10.1177/0194599818771931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。